U.S. Markets open in 1 hr 5 mins
  • S&P Futures

    3,460.00
    +10.75 (+0.31%)
     
  • Dow Futures

    28,361.00
    +93.00 (+0.33%)
     
  • Nasdaq Futures

    11,677.00
    +27.25 (+0.23%)
     
  • Russell 2000 Futures

    1,640.80
    +10.20 (+0.63%)
     
  • Crude Oil

    40.73
    +0.09 (+0.22%)
     
  • Gold

    1,915.50
    +10.90 (+0.57%)
     
  • Silver

    24.93
    +0.22 (+0.89%)
     
  • EUR/USD

    1.1860
    +0.0034 (+0.2846%)
     
  • 10-Yr Bond

    0.8480
    0.0000 (0.00%)
     
  • Vix

    27.65
    -1.00 (-3.49%)
     
  • GBP/USD

    1.3078
    -0.0002 (-0.0144%)
     
  • USD/JPY

    104.7100
    -0.1300 (-0.1240%)
     
  • BTC-USD

    12,947.36
    -19.37 (-0.15%)
     
  • CMC Crypto 200

    261.43
    +5.33 (+2.08%)
     
  • FTSE 100

    5,873.98
    +88.33 (+1.53%)
     
  • Nikkei 225

    23,516.59
    +42.32 (+0.18%)
     

Benzinga's Top Upgrades, Downgrades For September 18, 2020

Benzinga Insights
·8 mins read

Upgrades

  • For Fox Factory Holding Corp (NASDAQ: FOXF), Stifel upgraded the previous rating of Hold to the current rating Buy. Fox Factory Hldg earned $0.50 in the second quarter, compared to $0.68 in the year-ago quarter. The current stock performance of Fox Factory Hldg shows a 52-week-high of $113.41 and a 52-week-low of $34.58. Moreover, at the end of the last trading period, the closing price was at $75.59.

  • Morgan Stanley upgraded the previous rating for II-VI Inc (NASDAQ: IIVI) from Equal-Weight to Overweight. For the fourth quarter, II-VI had an EPS of $1.18, compared to year-ago quarter EPS of $0.67. The stock has a 52-week-high of $52.97 and a 52-week-low of $19.00. At the end of the last trading period, II-VI closed at $37.89.

  • For Kinross Gold Corp (NYSE: KGC), BMO Capital upgraded the previous rating of Market Perform to the current rating Outperform. In the second quarter, Kinross Gold showed an EPS of $0.15, compared to $0.06 from the year-ago quarter. The current stock performance of Kinross Gold shows a 52-week-high of $10.21 and a 52-week-low of $2.72. Moreover, at the end of the last trading period, the closing price was at $9.37.

  • Stifel upgraded the previous rating for Dave & Buster's Entertainment Inc (NASDAQ: PLAY) from Hold to Buy. For the second quarter, Dave & Buster's Enter had an EPS of $1.24, compared to year-ago quarter EPS of $0.90. At the moment, the stock has a 52-week-high of $48.80 and a 52-week-low of $4.61. Dave & Buster's Enter closed at $14.12 at the end of the last trading period.

  • Morgan Stanley upgraded the previous rating for SunPower Corp (NASDAQ: SPWR) from Underweight to Equal-Weight. In the second quarter, SunPower showed an EPS of $0.22, compared to $0.22 from the year-ago quarter. At the moment, the stock has a 52-week-high of $15.57 and a 52-week-low of $4.03. SunPower closed at $9.89 at the end of the last trading period.

 

Downgrades

  • For Apartment Investment & Management Co (NYSE: AIV), Citigroup downgraded the previous rating of Neutral to the current rating Sell. For the second quarter, Apartment Inv & Mgmt had an EPS of $0.63, compared to year-ago quarter EPS of $0.60. The current stock performance of Apartment Inv & Mgmt shows a 52-week-high of $55.68 and a 52-week-low of $24.53. Moreover, at the end of the last trading period, the closing price was at $36.38.

  • According to Citigroup, the prior rating for Mirati Therapeutics Inc (NASDAQ: MRTX) was changed from Buy to Neutral. Mirati Therapeutics earned $1.89 in the second quarter, compared to $1.26 in the year-ago quarter. The current stock performance of Mirati Therapeutics shows a 52-week-high of $171.48 and a 52-week-low of $66.01. Moreover, at the end of the last trading period, the closing price was at $161.97.

  • Wells Fargo downgraded the previous rating for NovoCure Ltd (NASDAQ: NVCR) from Overweight to Equal-Weight. NovoCure earned $0.02 in the second quarter, compared to $0.01 in the year-ago quarter. At the moment, the stock has a 52-week-high of $110.87 and a 52-week-low of $53.40. NovoCure closed at $108.98 at the end of the last trading period.

  • According to Chardan Capital, the prior rating for Seres Therapeutics Inc (NASDAQ: MCRB) was changed from Buy to Neutral. Seres Therapeutics earned $0.28 in the second quarter, compared to $0.24 in the year-ago quarter. At the moment, the stock has a 52-week-high of $33.00 and a 52-week-low of $2.52. Seres Therapeutics closed at $26.86 at the end of the last trading period.

  • According to JP Morgan, the prior rating for Beyond Meat Inc (NASDAQ: BYND) was changed from Neutral to Underweight. Beyond Meat earned $0.02 in the second quarter, compared to $0.06 in the year-ago quarter. The current stock performance of Beyond Meat shows a 52-week-high of $167.16 and a 52-week-low of $48.18. Moreover, at the end of the last trading period, the closing price was at $157.22.

  •  

Initiations

  • B. Riley FBR initiated coverage on Abeona Therapeutics Inc (NASDAQ: ABEO) with a Buy rating. The price target for Abeona Therapeutics is set to $5.00. Abeona Therapeutics earned $0.14 in the second quarter, compared to $0.49 in the year-ago quarter. The current stock performance of Abeona Therapeutics shows a 52-week-high of $5.19 and a 52-week-low of $1.35. Moreover, at the end of the last trading period, the closing price was at $1.96.

  • With a current rating of Buy, Berenberg initiated coverage on Ambarella Inc (NASDAQ: AMBA). The price target seems to have been set at $67.00 for Ambarella. In the second quarter, Ambarella showed an EPS of $0.06, compared to $0.21 from the year-ago quarter. The stock has a 52-week-high of $73.59 and a 52-week-low of $36.02. At the end of the last trading period, Ambarella closed at $52.19.

  • Compass Point initiated coverage on Argo Group International Holdings Ltd (NYSE: ARGO) with a Buy rating. The price target for Argo Gr Intl Hldgs is set to $41.00. For the second quarter, Argo Gr Intl Hldgs had an EPS of $0.14, compared to year-ago quarter EPS of $0.48. The stock has a 52-week-high of $70.89 and a 52-week-low of $25.00. At the end of the last trading period, Argo Gr Intl Hldgs closed at $35.59.

  • With a current rating of Outperform, Cowen & Co. initiated coverage on BioLife Solutions Inc (NASDAQ: BLFS). The price target seems to have been set at $33.00 for BioLife Solutions. In the second quarter, BioLife Solutions showed an EPS of $0.01, compared to $0.04 from the year-ago quarter. The stock has a 52-week-high of $28.28 and a 52-week-low of $7.37. At the end of the last trading period, BioLife Solutions closed at $25.43.

  • Goldman Sachs initiated coverage on Intellia Therapeutics Inc (NASDAQ: NTLA) with a Buy rating. The price target for Intellia Therapeutics is set to $33.00. For the second quarter, Intellia Therapeutics had an EPS of $0.61, compared to year-ago quarter EPS of $0.56. The stock has a 52-week-high of $25.56 and a 52-week-low of $9.18. At the end of the last trading period, Intellia Therapeutics closed at $22.45.

  • With a current rating of Buy, Benchmark initiated coverage on MACOM Technology Solutions Holdings Inc (NASDAQ: MTSI). The price target seems to have been set at $47.00 for MACOM Technology. For the third quarter, MACOM Technology had an EPS of $0.33, compared to year-ago quarter EPS of $0.42. The stock has a 52-week-high of $44.69 and a 52-week-low of $15.03. At the end of the last trading period, MACOM Technology closed at $32.79.

  • With a current rating of Hold, Truist Securities initiated coverage on Strategic Education Inc (NASDAQ: STRA). The price target seems to have been set at $105.00 for Strategic Education. In the second quarter, Strategic Education showed an EPS of $2.06, compared to $1.59 from the year-ago quarter. The current stock performance of Strategic Education shows a 52-week-high of $187.97 and a 52-week-low of $87.80. Moreover, at the end of the last trading period, the closing price was at $93.80.

  • With a current rating of Buy, Citigroup initiated coverage on Utz Brands Inc (NYSE: UTZ). The price target seems to have been set at $21.00 for Utz Brands. At the moment, the stock has a 52-week-high of $19.16 and a 52-week-low of $15.98. Utz Brands closed at $17.91 at the end of the last trading period.

  • With a current rating of Buy, Stifel initiated coverage on Construction Partners Inc (NASDAQ: ROAD). The price target seems to have been set at $21.00 for Construction Partners. For the third quarter, Construction Partners had an EPS of $0.30, compared to year-ago quarter EPS of $0.33. At the moment, the stock has a 52-week-high of $22.15 and a 52-week-low of $11.96. Construction Partners closed at $17.89 at the end of the last trading period.

  • With a current rating of Outperform, Wedbush initiated coverage on Retrophin Inc (NASDAQ: RTRX). The price target seems to have been set at $33.00 for Retrophin. For the second quarter, Retrophin had an EPS of $0.22, compared to year-ago quarter EPS of $0.58. The current stock performance of Retrophin shows a 52-week-high of $21.92 and a 52-week-low of $8.98. Moreover, at the end of the last trading period, the closing price was at $19.67.

  • Piper Sandler initiated coverage on Intuit Inc (NASDAQ: INTU) with an Overweight rating. The price target for Intuit is set to $351.00. Intuit earned $1.81 in the fourth quarter, compared to $0.09 in the year-ago quarter. The stock has a 52-week-high of $360.00 and a 52-week-low of $187.68. At the end of the last trading period, Intuit closed at $307.23.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.